News Release from IACP
IACP Foundation President, Shara Rudner, RPh, FIACP has announced that the organization has issued two new grants for pharmacy compounding research. “These studies will help add valuable information to the scientific literature and the Foundation was pleased to see so many exceptional responses to our second RFP of 2011,” said Rudner. “These projects are the direct result of contributions from IACP members to the Foundation’s agenda of advancing the science of compounding.”
A grant has been awarded to Grove Pharmacy in the amount of $15,860 for a research study to detail the process of performing beyond-use date (BUD) testing, as well as provide much needed BUD data on commonly prescribed Erectile Dysfunction (ED) sterile compounds under the guidance of Sarah Billings, Pharm.D., C.D.E., Director of Clinical Programs. A detailed description of the process that Grove Pharmacy undertakes to obtain sterility results for six concentrations of sterile ED medications will be written up and provided to IACP members.
The Foundation also is providing a grant of $10,000 to the Pacific University School of Pharmacy for a research study of the solid-state stability of compounded levothyroxine formulations. This project is a collaboration between the school’s pharmaceutical science faculty Deepa A. Rao, Ph.D. and clinical faculty member Jeff Fortner, Pharm.D. A summary report, poster, and a manuscript will be completed by the end of February 2013.
Since 2005, IACP Foundation has awarded more than $125,000 in grants to academicians and practitioners. The IACP Foundation Research division strongly believes research regarding pharmacy compounds is vital to strengthening the role of pharmacy in personalized medicine.
For more information, please click here.